Blood lipid and lipoprotein concentrations and colorectal cancer risk in the European Prospective Investigation into Cancer and Nutrition.
about
Lipidome in colorectal cancerApolipoprotein A-I and CancerStatins and cancersHow significant is the association between metabolic syndrome and prevalence of colorectal neoplasia?A genome-wide systematic analysis reveals different and predictive proliferation expression signatures of cancerous vs. non-cancerous cellsColorectal Cancer Classification and Cell Heterogeneity: A Systems Oncology ApproachImpact of platelet to lymphocyte ratio and metabolic syndrome on the prognosis of colorectal cancer patients.C1QBP is upregulated in colon cancer and binds to apolipoprotein A-I.Lipid levels in serum and cancerous tissues of colorectal cancer patientsDecreased serum apolipoprotein A1 levels are associated with poor survival and systemic inflammatory response in colorectal cancer.Specific metabolic biomarkers as risk and prognostic factors in colorectal cancer.Plasma lipid levels and colorectal adenoma riskCirculating Oxidized Low-Density Lipoproteins and Antibodies against Oxidized Low-Density Lipoproteins as Potential Biomarkers of Colorectal Cancer.A prospective study of the immune system activation biomarker neopterin and colorectal cancer risk.Efficacy of tomato concentrates in mouse models of dyslipidemia and cancer.Impact of cholesterol on disease progressionMetabolic serum biomarkers for the prediction of cancer: a follow-up of the studies conducted in the Swedish AMORIS studyDisentangling the Association between Statins, Cholesterol, and Colorectal Cancer: A Nested Case-Control StudyHDL mimetics inhibit tumor development in both induced and spontaneous mouse models of colon cancer.Development of a Novel Scoring System for Predicting the Risk of Colorectal Neoplasia: A Retrospective StudyTotal and high-molecular weight adiponectin and risk of colorectal cancer: the European Prospective Investigation into Cancer and Nutrition Study.Clinical significance of preoperative serum high density lipoprotein cholesterol levels in soft tissue sarcoma.Serum Lipids and the Risk of Gastrointestinal Malignancies in the Swedish AMORIS StudyMAPRE1 as a plasma biomarker for early-stage colorectal cancer and adenomasMetabolic syndrome contributes to an increased recurrence risk of non-metastatic colorectal cancer.Metabolic Mediators of the Association Between Adult Weight Gain and Colorectal Cancer: Data From the European Prospective Investigation into Cancer and Nutrition (EPIC) Cohort.Identification of Differentially Expressed Proteins in the Serum of Colorectal Cancer Patients Using 2D-DIGE Proteomics Analysis.Oxidized low-density lipoprotein is a common risk factor for cardiovascular diseases and gastroenterological cancers via epigenomical regulation of microRNA-210Progression of breast cancer following locoregional ipsilateral recurrence: importance of interval time.Influence of Obesity and Related Metabolic Alterations on Colorectal Cancer Risk.Serum lipid profiles and cancer risk in the context of obesity: four meta-analyses.Cellular immune activity biomarker neopterin is associated hyperlipidemia: results from a large population-based study.Delivery of Flavonoids and Saponins from Black Bean (Phaseolus vulgaris) Seed Coats Incorporated into Whole Wheat BreadSerum apolipoprotein A-I is a novel prognostic indicator for non-metastatic nasopharyngeal carcinoma.Lipid biomarkers and long-term risk of cancer in the Women's Health StudyErythrocyte membrane fatty acid composition, serum lipids, and non-Hodgkin's lymphoma risk in a nested case-control study: the multiethnic cohort.The Effect of Preoperative Apolipoprotein A-I on the Prognosis of Surgical Renal Cell Carcinoma: A Retrospective Large Sample Study.High-density lipoprotein cholesterol as a predictor of poor survival in patients with nasopharyngeal carcinoma.Parameters of Glucose and Lipid Metabolism Affect the Occurrence of Colorectal Adenomas Detected by Surveillance Colonoscopies.Colorectal cancer association with metabolic syndrome and its components: a systematic review with meta-analysis.
P2860
Q26766296-5C7A8163-1ABD-42AF-87A3-3E48B60E67B5Q26776188-63AB4538-4AE7-4FEA-8FB2-0C69B3191D78Q26777793-0206059E-A77B-475F-8E44-386612EE93AAQ28067170-0AB2C6E2-6B81-471F-B175-5E36BF4F23F8Q28533665-F6AB47A9-CFA7-47C8-920E-5F0356821060Q28647615-0809F9AA-ABBE-4019-9888-717022D6F04AQ33596891-785003C0-94D9-4490-9C29-AD778E5FEDA4Q33724223-4FC76E42-A040-4726-9535-2DAD08ADCE58Q33887103-8C38FFEA-DBA7-4E5E-A0D1-74864093D245Q33905987-9BC41AD6-8019-4AF0-A345-0AABA070C353Q34008787-3ED9A70F-75B8-4EEC-A07A-800B8D66E14FQ35222154-A2322EED-6F06-4D1C-97C7-A2B49A718EB8Q35412584-02FED4E9-6343-4A6F-99F8-326C39CC6E98Q35474078-BE6C5FA0-6DA1-469F-9A3C-B35A19746C9FQ35822272-4C3A3149-B4CC-4DD7-82E8-F5FB6701D65BQ35850911-82F47784-E53F-4F27-AD32-B8FC4BA308D2Q35935362-DB3945EC-C645-41BB-90A3-ABA660CC944CQ35999696-E378F448-B94E-4978-81EA-D9E5BB6143DFQ36028380-2F317330-4090-4024-9CD0-A4F265F2AC56Q36047981-278F0BAB-33F3-496D-ACED-651B42F7B359Q36072581-A18616BA-1E72-4D32-AE6A-37BAF183251EQ36151318-8CAE8976-A668-4187-BD0F-B16B8A763755Q36219627-A7AC5BF5-2999-464C-8FBB-4CC530946010Q36249105-AA15F185-01F1-40EF-9DFE-FE839F816826Q36260667-1060EEF1-5211-40A5-B3AF-73CA9F6F5659Q36339523-1F9A5CD7-5167-4AC7-95E9-D6F2BBDB1A35Q36378584-8F95B5CC-E3D6-4799-9E87-EF5CA6F02BCFQ36414391-EC0549DF-494B-4DB8-95F3-58E40C1FED9AQ36472953-6D3DDD6B-43E1-495A-AAA9-FE42379FCC5CQ36582321-C1758607-9133-44B3-A05B-4807ACFF594EQ36584255-67E4664B-4A49-40FE-B3EF-6CA2B08AFE75Q36616633-44F8EC59-5E08-4C80-9C4B-AC4859616B5FQ36667118-9628E9AC-B954-4AD8-8269-946B0914606AQ36685565-35015F7E-3645-4A93-93B0-B5DD7C32314CQ36937615-4C7AEEB1-8ABF-44E9-A66C-7CEB3062A068Q37147231-0331E416-BE2C-40FF-AC37-ACBEF0CD6E7EQ37205399-DF486F18-8320-49DD-8BE0-0367F7A79582Q37536465-87430D7D-C3EE-4E5A-AB89-613E87AB5180Q37622151-96EA2B4F-4DFD-4464-9B55-C9AD40F4341EQ38094977-788593A6-3616-4A98-9F7A-95AAB0276EF7
P2860
Blood lipid and lipoprotein concentrations and colorectal cancer risk in the European Prospective Investigation into Cancer and Nutrition.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Blood lipid and lipoprotein co ...... ion into Cancer and Nutrition.
@en
Blood lipid and lipoprotein co ...... ion into Cancer and Nutrition.
@nl
type
label
Blood lipid and lipoprotein co ...... ion into Cancer and Nutrition.
@en
Blood lipid and lipoprotein co ...... ion into Cancer and Nutrition.
@nl
prefLabel
Blood lipid and lipoprotein co ...... ion into Cancer and Nutrition.
@en
Blood lipid and lipoprotein co ...... ion into Cancer and Nutrition.
@nl
P2093
P50
P356
P1433
P1476
Blood lipid and lipoprotein co ...... ion into Cancer and Nutrition.
@en
P2093
Amir Ayyobi
Birgit Teucher
Dagmar Drogan
Eugène H J M Jansen
Francesca L Crowe
Fränzel J B van Duijnhoven
H Bas Bueno-De-Mesquita
Jiri Frohlich
Kostas K Tsilidis
Laudina Rodríguez
P304
P356
10.1136/GUT.2010.225011
P407
P50
P577
2011-03-07T00:00:00Z